Conciliatory meetings between Toyota Kirloskar Motor’s management and employees’ union have failed, with the two …
Infosys on Tuesday annouced a salary hike of 6-7% for its employees effective April.
Despite overall market sentiments remaining muted, Infosys president BG Srinivas believes…
SpiceJet and IndiGo on Tuesday merged fuel surcharge with the base fares, saying it would simplify the prevailing fare structure.
In one of its best performances, Tata Steel posted a 14% y-o-y sales growth in FY14 at 8.52 million tonne…
Nokia India on Tuesday rolled out a month-long voluntary retirement scheme (VRS) at its manufacturing plant in Chennai.
Aurobindo Pharma had filed for the approval of 250 mg vial of generic Angiomax with the US Food and Drug…
Plans houses on land parcel, expects clearances in 12-18 months
Bids for the privatisation of six Indian airports have been postponed once again…
The Supreme Court on Tuesday asked the three Aluminum Phosphide Tablets (APT) manufacturers and the Competition Commission of India
Election outcome will give insight into new govt?s ability to implement reforms
Generic drug players like Natco Pharma and Lupin are finding it tough to launch new products
Retail inflation also surged after hitting a 25-month low in February.
Riding Narendra Modi wave, Gujarat-based firms listed on stock exchanges feature among top performers…
Stock rises as Infosys ups dividend payout ratio to 40% from 30%.
Yes Bank is fighting an adverse macro on multiple fronts ? yields have been rising since April and there are…
We upgrade Titan to ?overweight? from ?neutral? with a new target price of Rs 300.
The Infosys scrip gained more than 4% intra-day after the company reported better-than-expected earnings for the quarter ended March 2014.
